These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 5273020)

  • 1. Experimental study on peritoneal dialysis using xylitol-containing solution.
    Yen TS
    Taiwan Yi Xue Hui Za Zhi; 1970 Jun; 69(6):292-304. PubMed ID: 5273020
    [No Abstract]   [Full Text] [Related]  

  • 2. [An experimental study on metabolic rate of glucose given with fructose and xylitol solution in rabbits].
    Sato K; Ikeda K; Oomura M; Takahashi H; Sodeyama O
    Masui; 1984 Jul; 33(7):737-9. PubMed ID: 6438362
    [No Abstract]   [Full Text] [Related]  

  • 3. Experimental study on peritoneal dialysis in uremia.
    Yen TS
    Taiwan Yi Xue Hui Za Zhi; 1977 Mar; 76(3):230-7. PubMed ID: 266575
    [No Abstract]   [Full Text] [Related]  

  • 4. [Studies on acid-base equilibrium and infusion fluid, in pediatric surgery].
    Sato M; Satomi M; Kaya K; Yamanaka I; Kawamura R
    Masui; 1967 Mar; 16(3):184-91. PubMed ID: 6070791
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effects of glucose, xylitol and dihydroxyacetone infusions on the metabolism and the fluctuation of plasma insulin levels in non-diabetic and diabetic patients and in dogs subjected to hemorrhagic shock].
    Yoshimura N; Kodama K; Nobe S; Suemori I; Yoshida Y
    Masui; 1971 Jan; 20(1):42-50. PubMed ID: 5102303
    [No Abstract]   [Full Text] [Related]  

  • 6. [Application of Klinit as a base solution of dripping infusion in ocular treatment].
    Imaizumi K; Shoji U; Mita K; Sato Y
    Nihon Ganka Kiyo; 1970 Sep; 21(9):653-8. PubMed ID: 5529297
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of xylitol on the gastric secretion in dogs].
    Vainshteĭn SG
    Farmakol Toksikol; 1971; 34(1):97. PubMed ID: 5563381
    [No Abstract]   [Full Text] [Related]  

  • 8. [Studies on the prevention of side-effects of the anti-cancer agent, mitomycin C by xylitol].
    Iwasa H; Takahashi M
    Gan No Rinsho; 1968 Jul; 14(7):561-5. PubMed ID: 5749780
    [No Abstract]   [Full Text] [Related]  

  • 9. Peritoneal dialysis with solutions low in glucose degradation products is associated with improved biocompatibility profile towards peritoneal mesothelial cells.
    Witowski J; Korybalska K; Ksiazek K; Wisniewska-Elnur J; Jörres A; Lage C; Schaub TP; Passlick-Deetjen J; Breborowicz A; Grzegorzewska A; Ksiazek A; Liberek T; Lichodziejewska-Niemierko M; Majdan M; Rutkowski B; Stompór T; Sulowicz W
    Nephrol Dial Transplant; 2004 Apr; 19(4):917-24. PubMed ID: 15031350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of anaesthesia on fluid and solute transport in a C57BL6 mouse model of peritoneal dialysis.
    Shin SK; Kamerath CD; Gilson JF; Leypoldt JK
    Nephrol Dial Transplant; 2006 Oct; 21(10):2874-80. PubMed ID: 16877489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amphotericin B, mercury chloride and peritoneal transport in rabbits.
    Zweers MM; Douma CE; de Waart DR; Korevaar JC; Krediet RT; Struijk DG
    Clin Nephrol; 2001 Jul; 56(1):60-8. PubMed ID: 11499660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of electrolytes, components of peritoneal dialysis fluid, on the stability of glucose].
    Trzeciak M; Zakrzewski Z; Siedlecka E; Furmańczyk Z
    Acta Pol Pharm; 1989; 46(2):174-8. PubMed ID: 2631572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional and structural alterations of peritoneum and secretion of fibrotic cytokines in rats caused by high glucose peritoneal dialysis solutions.
    Liu Y; Li JF; Liu H; Liu FY; Peng YM; Liu YH; Cheng MC; Chen GC; Zhou X
    Ren Fail; 2014 Mar; 36(2):292-9. PubMed ID: 24152223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effects of glycylglycine peritoneal dialysis solution with neutral pH on peritoneum in rats.
    Wieczorowska-Tobis K; Korybalska K; Polubińska A; Radkowski M; Breborowicz A; Montagne A; Oreopoulos DG
    Adv Perit Dial; 1997; 13():42-6. PubMed ID: 9360649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of three chronic dialysis models.
    Peng WX; Guo QY; Liu SM; Liu CZ; Lindholm B; Wang T
    Adv Perit Dial; 2000; 16():51-4. PubMed ID: 11045261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between a glucose-fructose-xylitol solution and a sole glucose solution for surgical patients with glucose tolerance impairment.
    Muñoz NA; Takehara H; Nishi M; Komi N
    Tokushima J Exp Med; 1990 Dec; 37(3-4):83-8. PubMed ID: 2094065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor in peritoneal dialysis: a longitudinal follow-up.
    Zweers MM; Struijk DG; Smit W; Krediet RT
    J Lab Clin Med; 2001 Feb; 137(2):125-32. PubMed ID: 11174469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of new dialysis solutions on clinical results in patients treated with peritoneal dialysis].
    Haag-Weber M
    Wien Klin Wochenschr; 2005; 117 Suppl 6():89-97. PubMed ID: 16437339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute effects of peritoneal dialysis solutions in the mesenteric microcirculation.
    Frajewicki V; Brod V; Kushnir D; Kohan R; Bitterman H
    Transl Res; 2009 May; 153(5):249-56. PubMed ID: 19375686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of ciprofloxacin injection in peritoneal dialysis solutions.
    Kane MP; Bailie GR; Moon DG; Siu I
    Am J Hosp Pharm; 1994 Feb; 51(3):373-7. PubMed ID: 8160691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.